ARCHIVES

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

This article is from The Cancer Letter archive.

Vol. 18 No. 14 | April 3, 1992

Download PDF Visit The Full Archive

Related Articles

Greenberg: More Work Needs to be Done

November 7, 2014

OMB Backs Down, Releases New Construction Funds After Ruling They Are “Alteration, Renovation”

December 13, 1974

NCI Evaluating PDQ Evaluation

September 1, 1989

House Subcommittee Recommends $137.7 Million Increase For NCI

June 21, 1996

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

DCBD To Fund Diagnostic Clinical Trials By CCOPs, Cooperative Groups

June 30, 1989